TradingMenu expanded
Forge Markets Forge Pro Browse Companies
DataMenu expanded
Forge Data Private Market Index Forge Accuidity Index IPO Stock Tracker
SolutionsMenu expanded
For Institutions For Shareholders For Investors For Companies In Europe
InsightsMenu expanded
All Insights Blog Glossary Reports Videos Webinars
Popular Topics
Buying Pre-IPO Shares Selling Pre-IPO Shares Private Market Updates Forge Investment Outlook Startup News Tech IPO Calendar for 2024
AboutMenu expanded
About Us Team Investor Relations People & Culture Careers FAQs
Log In Sign Up
Trading Menu expandedTrading
Forge Markets
Forge Pro
Browse Companies
Data Menu expandedData
Forge Data
Private Market Index
Forge Accuidity Index
IPO Stock Tracker
Solutions Menu expandedSolutions
For Institutions
For Shareholders
For Investors
For Companies
In Europe
Insights Menu expandedInsights
All Insights
Blog
Glossary
Reports
Videos
Webinars
Popular Topics
Buying Pre-IPO Shares
Selling Pre-IPO Shares
Private Market Updates
Forge Investment Outlook
Startup News
Tech IPO Calendar for 2024
About Menu expandedAbout
About Us
Team
Investor Relations
People & Culture
Careers
FAQs
Trading / Browse Private Companies / Pear Therapeutics Stock

Pear Therapeutics Stock

peartherapeutics.comHealthcare / Digital HealthFounded: 2013Funding to Date: $139MM

Pear discovers, develops, and delivers clinically-validated software-based therapeutics to provide better outcomes for patients, smarter engagement and tracking tools for clinicians, and cost-effective solutions for payers.

Learn more about Pear Therapeutics IPO

Register To Buy and Sell Shares

For more details on financing and valuation for Pear Therapeutics, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

OverviewFinancingsValuation

Enterprise Value

Powered by Forge Data

Access Pear Therapeutics’ valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Pear Therapeutics.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.

Register

Animation displayed is not current and securities are shown for illustrative purposes only.

Team

Management Team

Alex Waldron
Chief Commercial Officer
Stephen Smith JD
Co-Founder & Executive Vice President of Corporate Development
Walter Greenleaf Ph.D
Chief Science Advisor
Christopher Guiffre JD
Chief Operating Officer & Chief Financial Officer
Yuri Maricich MD
Chief Medical Officer & Head of Clinical Development
Jeffrey Lieberman
Advisor
Corey McCann Ph.D
Co-Founder, President, Chief Executive Officer & Board Member
Jeremy Gilbert
Chief Product Officer
Beth Rogozinski
Chief Content Advisor

Board Members

Andrew Schwab
5AM Ventures
John Harris
JAZZ Venture Partners
Zack Lynch
JAZZ Venture Partners
Corey McCann Ph.D
Jeremy Sohn
Timothy Petersen
Arboretum Ventures
Delaine Cheong
Temasek Holdings
Jamil Beg
5AM Ventures
Thomas Shehab MD
Arboretum Ventures
Hu Hongjie
Temasek Holdings

Other companies like Pear Therapeutics in the Digital Health sector

OURA

Sector
Healthcare / Digital Health
 
 

Brightline

Sector
Healthcare / Digital Health
Last Round Est. Valuation
$705.25MM

ZocDoc

Sector
Healthcare / Digital Health
Last Round Est. Valuation
$2.62B

Hinge Health

Sector
Healthcare / Digital Health
Last Round Est. Valuation
$6.2B

Ro

Sector
Healthcare / Digital Health
Last Round Est. Valuation
$7.19B

Calm

Sector
Healthcare / Digital Health
Last Round Est. Valuation
$404.67MM

Maven

Sector
Healthcare / Digital Health
Last Round Est. Valuation
$1.35B

Included Health

Sector
Healthcare / Digital Health
Last Round Est. Valuation
$1.13B

PathAI

Sector
Healthcare / Digital Health
Last Round Est. Valuation
$1.11B

News Highlights

Mobi Health News 01/07/2019
Pear Therapeutics rakes in $64M for reSET commercialization, product development
The latest funding was led by Temasek, with participation from Novartis, 5AM Ventures, Arboretum Ventures, Jazz Partners, The Bridge Builders Collaborative and EDBI.

Trending Companies

Frequently Asked Questions

Updated on: Apr 25, 2024

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.